Biologics for the Treatment of Inflammatory Bowel Disease

Reflections surrounding challenges in inflammatory bowel disease management, and appropriate treatment strategies that can be used to optimize treatment for patients with ulcerative colitis or Crohn’s disease.

EP. 1: Ulcerative Colitis Versus Crohn’s

October 6th 2021

Risk factors and characteristics that distinguish ulcerative colitis from Crohn’s disease.

EP. 2: Referral and Differential Diagnosis of IBD

October 6th 2021

Red flag symptoms that should prompt a primary care physician to refer a patient to a gastroenterologist for proper assessment for a potential inflammatory bowel disease.

EP. 3: IBD: Evaluating Severity and Extent of Disease

October 12th 2021

Criteria used by gastroenterologists to evaluate patients with an inflammatory bowel disease for relapses or disease progression.

EP. 4: Diagnostic Work-up for a Patient With Symptoms of IBD

October 12th 2021

GI specialists review the case of a 24-year-old woman who presents with symptoms that suggest inflammatory bowel disease and suggest how they would appropriately test and diagnose the patient before initiating therapy.

EP. 5: Treatment Options for Ulcerative Colitis and Crohn's Disease

October 20th 2021

A review of various classes of biologic therapies available to treat patients with ulcerative colitis or Crohn's disease.

EP. 6: Oral, Small Molecule Agents for Ulcerative Colitis

October 20th 2021

What to know in terms of integrating new oral, small molecule targeted drugs into treatment plans for patients with ulcerative colitis.

EP. 7: Measuring Treatment Response in Patients With IBD

October 27th 2021

Recommendations when assessing response to biologic therapies used to treat ulcerative colitis and Crohn disease.

EP. 8: Selecting a Biologic Therapy for IBD

October 27th 2021

Factors that impact which biologic therapy a gastrointestinal specialist may initiate for a patient with inflammatory bowel disease, especially during the COVID-19 pandemic.

EP. 9: Monitoring a Patient on Biologic Therapy Used for IBD

November 3rd 2021

Recommendations for monitoring a 24-year-old woman treated with biologic therapy to manage inflammatory bowel disease to evaluate treatment efficacy.

EP. 10: IBD: Managing Ongoing Disease Activity

November 3rd 2021

How to best treat a patient with inflammatory bowel disease who demonstrates no disease response to initial biologic treatment, as well as insight surrounding the treatment of patients who develop perianal disease.